J. Christopher Condit

chris condit

B.S. Electrical Engineering 2004, M.S. Biomedical Engineering 2011
Senior R&D Engineer, Abbott Neuromodulation
Founder, Texas 4000 for Cancer

Chris Condit is the founder of Texas 4000 for Cancer and is a senior R&D engineer at Abbott Neuromodulation, where he has also held clinical and marketing roles.

Condit filed his first patent in laser imaging as an undergraduate researcher at the university. This patent was licensed by medical device startup CardioSpectra, which Condit joined as an R&D engineer after graduating. After CardioSpectra, he returned to UT Austin to continue his education and joined Abbott Neuromodulation, a biomedical engineering company, upon completing his master’s degree. During his time at Abbott, Condit has helped develop and launch several major product platforms, including an industry-first implantable deep brain stimulation system programmed and controlled wirelessly using Apple devices. He is an inventor on six issued or pending patents and a co-author on nine journal publications.

Read more

DEG Honorees

A "Distinguished Engineering Graduate" (DEG) is a graduate who has presented him or herself to the world as a consummate professional and dedicated engineer. Learn more about past DEG honorees.